← Back to catalogue

Alere Determine HIV-1/2 Ag/Ab Combo Controls

FDA UDI

by Orgenics, Ltd.

Identity

Trade Name
Alere Determine HIV-1/2 Ag/Ab Combo Controls FDA UDI
Generic Name
HIV1/HIV2 antigen/antibody IVD, control FDA UDI
Device Name
Contents HIV-1 Reactive Control, 1.5 mL HIV-2 Reactive Control, 1.5 mL P24 Antigen Control, 1.5 mL HIV Nonreactive Control, 1.5 mL FDA UDI
Model / Reference
Alere Determine HIV-1/2 Ag/Ab Combo Cont FDA UDI
Description
Contents HIV-1 Reactive Control, 1.5 mL HIV-2 Reactive Control, 1.5 mL P24 Antigen Control, 1.5 mL HIV Nonreactive Control, 1.5 mL FDA UDI

Identifiers

Catalog Number
7D2628 FDA UDI
Primary DI / UDI-DI
07290015003759 FDA UDI
GMDN Term
HIV1/HIV2 antigen/antibody IVD, control FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: HIV1/HIV2 antigen/antibody IVD, control

Alere Determine HIV-1/2 Ag/Ab Combo Controls by Orgenics, Ltd. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as HIV1/HIV2 antigen/antibody IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Orgenics, Ltd.

Sources (1)

  • FDA UDI d433d2b3-af8a-44c7-a039-d7c6c5b4f5be 36 fields · synced May 30, 2026